Dr. Osborne’s Passion
Since 2007, Dr Osborne has dedicated countless hours to the Osborne Head and Neck Foundation, a non-profit 501-c3 corporation, with the intention of building stronger communities both domestically and internationally. The Foundation focuses on access to healthcare, education, technology, and community business development.
Speaking Engagements
Dr. Osborne’s speaking engagements cover important and profound concepts in a format that is easy to digest. He’s a teacher at heart and his storytelling is engaging, interactive, and ties personal experiences, which in turn makes his speaking engagements very relatable.
Dr. Osborne 360˚
Under the umbrella of OHNI and Osborne Head and Neck Foundation, Dr. Osborne has traveled to and performed complex surgeries throughout the world.
This unique background has gifted him the opportunity to see many different ways to solve a problem.
This unique background has gifted him the opportunity to see many different ways to solve a problem.
Compassionate Care
Eagle Syndrome
Eagle Syndrome is the presence of an elongated styloid process and or the calcification of the stylohyoid ligament. An elongated styloid is found in approximately 4% of the population. Dr. Ryan F. Osborne’s practice is comprised of patients with complex or rare conditions that require surgical intervention.
Dr. Osborne completed a fellowship in advanced head and neck surgical oncology during which he trained operating on a regular basis around the cranial nerves and large vascular structures such as the internal jugular vein and carotid artery, the same critical structures being affected in Eagle’s Syndrome. He has a pragmatic approach when deciding on the best treatment option for his patients, constantly considering the risks vs benefits of each potential intervention.
Dr. Osborne completed a fellowship in advanced head and neck surgical oncology during which he trained operating on a regular basis around the cranial nerves and large vascular structures such as the internal jugular vein and carotid artery, the same critical structures being affected in Eagle’s Syndrome. He has a pragmatic approach when deciding on the best treatment option for his patients, constantly considering the risks vs benefits of each potential intervention.
Parotid and Salivary Gland Stones
The non-surgical removal of salivary gland stones causing swelling and infection of the major salivary glands is accomplished through a minimally invasive outpatient endoscopic procedure called sialendoscopy that requires no surgical incisions, leaves no scars, and carries a zero percent risk of facial nerve paralysis.
Dr. Ryan Osborne is one of a handful of surgeons in the world that have championed the use sialendoscopy for the safe removal of salivary gland stones, avoiding invasive surgical procedures.
Dr. Ryan Osborne is one of a handful of surgeons in the world that have championed the use sialendoscopy for the safe removal of salivary gland stones, avoiding invasive surgical procedures.
Head And Neck Tumors
The parotid gland is the most frequent site of salivary gland tumor occurrence. Over 80% of all salivary gland tumors occur within the parotid gland. Tumors of the parotid gland can be separated into two main categories based on behavior, benign and malignant.
Benign tumors are typically non-aggressive cell growths that result from a variety of aberrant intracellular events. These tumors typically grow slowly over time, are painless, and do not invade or destroy adjacent tissues. Benign parotid tumors can however compress adjoining structures and cause dysfunction of surrounding structures based purely on their space occupying effects.
Benign tumors are typically non-aggressive cell growths that result from a variety of aberrant intracellular events. These tumors typically grow slowly over time, are painless, and do not invade or destroy adjacent tissues. Benign parotid tumors can however compress adjoining structures and cause dysfunction of surrounding structures based purely on their space occupying effects.
Neurofibromatosis (NF)
Neurofibromatosis (NF) is a genetic disorder that causes tumors to develop on nerve tissues.
Neurofibromatosis Type 1 (NF1) affects approximately 1 in 3,000 people. It is caused by a genetic mutation that disrupts the production of the protein neurofibromin, which is essential for regulating cell growth.
NF1 causes changes in skin pigmentation, the appearance of café-au-lait spots (light brown patches on the skin), and the growth of benign tumors known as neurofibromas. Though typically found on the face and neck, these tumors can appear on other parts of the body. These tumors are typically non-cancerous, but there is a possibility they may become malignant over time.
Neurofibromatosis Type 1 (NF1) affects approximately 1 in 3,000 people. It is caused by a genetic mutation that disrupts the production of the protein neurofibromin, which is essential for regulating cell growth.
NF1 causes changes in skin pigmentation, the appearance of café-au-lait spots (light brown patches on the skin), and the growth of benign tumors known as neurofibromas. Though typically found on the face and neck, these tumors can appear on other parts of the body. These tumors are typically non-cancerous, but there is a possibility they may become malignant over time.
OHNI MOBILE APP
With our app you can download patient forms, message your nurse, make a payment, schedule appointments, and much, much more.
